CD274 and neoplasm: In the current manuscript, we now expand on our previous findings by using a novel method of chimeric tumor modeling to generate partially PDL1+ tumors in immune competent animals and study how this partial PDL1 positivity impacts the outcomes of virally induced immunotherapy.